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Abstract 
The response of an Electrochemical Impedance Spectroscopy (EIS) sensor using DNA aptamers is 
affected by many factors such as DNA density, charge and conformational changes upon DNA-target 
binding and buffer conditions. We report here for the first time on the optimisation of an EIS aptamer-
based sensor by using Quartz Crystal Microbalance with Dissipation mode (QCM-D). As a case study 
we employed a DNA aptamer against Prostate Specific Antigen (PSA). PSA detection was achieved 
by functionalizing the gold sensor surface via thiol chemistry with different ratios of thiolated-DNA 
aptamer and 6-mercapto-1-hexanol (MCH) used as spacer molecules. PSA binding efficiency can be 
monitored by measuring QCM-D signals which not only provides information about the mass of PSA 
bound on the sensor surface but also crucial information about the aptamer conformation and layer 
hydration.  
Data generated through QCM-D analysis provided the optimal conditions in terms of aptamer/MCH 
ratio to maximize the PSA binding. The ratio of 1:200 for DNA aptamer/spacer molecule was found 
to be optimal for ensuring maximum PSA binding. However, this study showed how a maximum 
analyte binding does not necessarily correspond to a maximum EIS response, which revealed to be 
enhanced if a ratio of 1:100 for DNA aptamer/spacer molecule was used. Moreover, by monitoring 
the QCM-D signal, for the first time a value of the dissociation constant (Kd), equal to 37 nM, was 
found for the PSA DNA aptamer towards its target. The combination of QCM-D with EIS techniques 
provide further insight into the effects of mass loading and charge effects that govern the response of 
an EIS aptasensor, serving as a valuable support for future EIS aptamer-based applications.  
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1. Introduction 
A global demand for cost-effective, reliable and rapid tools for the early detection of disease markers 
has led to an intensive study of label-free biosensors in the last decade as point-of-care diagnostic 
platforms. Label-free sensors represent the new frontier for DNA-based detection. The lack of 
labelling processes lowers their individual expense and responses are more rapid when compared to 
enzyme or fluorescent-labelled assays (Keighley et al., 2008). Furthermore, label-free DNA-based 
sensors can be widely employed in achieving high genosensor sensitivity for genetic disease and 
forensic detection applications. One of the most promising label-free measurement techniques for 
DNA applications is Electrochemical Impedance Spectroscopy (EIS). EIS measures changes in 
electrode impedance upon target recognition, with reported sensitivities down to attomolar ranges 
(Bertok et al., 2013). 
Antibodies currently represent the gold standard in modern biosensing platforms for protein detection. 
However, antibodies are affected by some disadvantages, particular to their in vivo production. In vivo 
conditions hamper freedom in manipulating processes and can lead to significant batch-to-batch 
variability (Keefe et al., 2010). Moreover, the shelf lives of antibodies can prevent their effective 
integration into biosensor platforms (McKeague et al., 2011). Alternatively, DNA aptamers are 
produced by in vitro selection of functional nucleic acids through a process called Systematic 
Evolution of Ligands by Exponential enrichment (SELEX) (Stoltenburg et al., 2007). Unlike 
antibodies, DNA aptamers can be inexpensively synthesized and chemically modified with high 
purity and reproducibility. Furthermore, they are small in size, chemically stable and can target not 
only small molecules but also large proteins and cells, while exhibiting affinities and sensitivities 
similar to antibodies (Song et al., 2008). Their continued generation and investigation is consistently 
grouped around their application as biorecognition agents in diagnostic and therapeutic technologies.  
In this study, we investigated the correlations between EIS and QCM-D signals of an aptasensor, 
using the detection of prostate-specific antigen (PSA) with a DNA aptamer as a case study. PSA is a 
33-34 kDa glycoprotein produced by the prostate, a gland which liquefies semen in order to increase 
sperm mobility. Altered levels of PSA in blood above the cut off level of 120 pM might be associated 
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with prostate cancer (PCa) (Gilgunn et al., 2013). PCa is the second worldwide leading cause of 
cancer-related mortality amongst men (Ferlay et al., 2013). The slow progression, coupled with the 
lack of symptoms during the first stages of the disease, often leads to a late diagnosis of the tumour, 
hampering the efficacy of medical interventions. At present, the most reliable screening consists of 
histological analysis performed by collecting sample tissues through a biopsy (Lilja et al., 2008; 
Gilgunn et al., 2013). However, such procedure can produce several inconveniences (Basch et al., 
2012) such as infection complications. The decision of whether or not performing a biopsy is largely 
based on digital rectal examination and the measurement of PSA blood levels. 
Current label-free detection systems for PSA involve mostly antibody-based electrode fabrication. 
Arya & Bhansali (2012) proposed a sensing system where gold electrodes are functionalized with a 
cysteamine self-assembled monolayer (SAM) by using conventional EDC/NHS chemistry. Li et al. 
(2005) proposed a combined use of In2O3 nanowires and p-type carbon nanotubes, where antibodies 
are immobilized through succinimidyl linking molecules. Chiriacò et al. (2013) developed an EIS 
sensor for both total and free PSA detection on gold electrodes by exploiting two different antibodies 
and using a SAM made of 11-mercaptoundecanoic acid and 2-mercaptoethanol and EDC/NHS 
chemistry. 
At present, very few studies on PSA detection using an aptasensor have been reported (Jolly et al., 
2015a), all of them using the sequence developed by Savory et al. (2010). Liu et al. (2012) performed 
Differential Pulse Voltammetry (DPV) measurements on graphite electrode with gold nanoparticles 
encapsulated by graphitized mesoporous carbon, exploiting biotinylated-aptamer/streptavidin 
coupling, achieving a limit of detection (LOD) of 7 pM with a dynamic range from 7 pM to 6 nM. 
Cha et al. (2014) reported on a chemiluminescent resonance energy transfer aptasensor for PSA with a 
LOD of 30 pM. A chemiluminescent aptasensor able to remove impurities that hamper PSA detection 
in human serum with sensitivity comparable to enzyme immunoassays was developed by Choi & Lee 
(2013). A detection limit as low as 5 aM was achieved by Ma et al. (2014) employing a sensor based 
on surface enhanced Raman scattering in serum samples. Jolly et al. (2015b), instead, reported on an 
EIS aptamer-based aptasensor that makes use of the anti-fouling properties of sulfo-betaine molecules 
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for the formation of the SAM. Chen et al. (2012) instead, proposed an optical method of detection in 
the range 4 pM to 3 nM with LOD of ~1 pM, based on a resonance light-scattering (RLS) and gold 
nanoparticles assay where the changes in aptamer conformation upon PSA recognition is exploited. 
Although EIS aptasensors are extremely promising, a careful optimization of the factors that can 
cause undesired signal changes is required. It is known that the immobilised DNA density and the 
hydration, charge and conformation of the biomolecular sensing layer can affect the EIS response 
(Radi & O’Sullivan, 2006). Moreover, the amount of DNA aptamer on the secondary structure (i.e. 
upon antigen binding, which conformation requires a higher energy state) also depends on steric 
hindrance effects as well as on the DNA density which directly affects the electrostatic interactions 
between DNAs. The support of Quartz Crystal Microbalance with Dissipation mode (QCM-D) can 
provide valuable information on the status of the biolayer, such as the amount of bound mass and the 
viscoelastic properties of the film. The QCM-D system allows real time measurements of the mass 
bound at the interface of a gold-coated quartz crystal, which can inform certain properties of 
immobilised biomolecules for sensing purposes (Fogel et al., 2007; Fogel & Limson, 2011). The 
measurements are carried out by monitoring resonance frequency and energy dissipation changes 
happening at the interface of the oscillator when this is excited at its fundamental resonance frequency 
or integer odd multiples. Here, we (i) compare EIS with QCM-D signals in order to obtain the best 
conditions that maximize the response of an EIS aptasensor using, as a case study, PSA as a target 
analyte and (ii) we provide further understanding of the EIS response for aptamer-based sensors 
which can be used as valuable support for future applications. 
The principle of detection of the aptasensor is described in figure 1. A DNA aptamer raised against 
PSA (Savory et al., 2010) was used to specifically bind the target. Since functionalization of the 
electrodes with mixed SAMs fosters a better SAM formation for electrochemical applications (Steel et 
al., 1998), in order to increase the performance of the biosensor, a mixed SAM was employed where 
the thiolated DNA served as capture probe and MCH was chosen as a spacer molecule. MCH was 
included in order to alter the lateral density of thiolated DNA on the surface; this was to passivate the 
gold surface and reduce non-specific binding as well as minimise steric hindrance and facilitate the 
6 
 
charge transfer during the EIS measurements (Keighley et al., 2008). Although gold-sulphur bonds 
happen relatively quickly, a longer exposure (such as 16 hours) with the alkanethiols solution leads to 
the formation of a well-organized SAM structure which ensures a better approaching of the 
ferri/ferrocyanide redox couples [Fe(CN)6]3-/4- to the electrode surface, thereby yielding a more 
reliable EIS recording (Love et al., 2005).  
Since aptamer conformation can be very sensitive to the environment where aptamers are employed 
(Pestourie et al., 2006; Radi & O’Sullivan, 2006), important conditions such as aptamer/MCH ratio 
used for the sensor surface functionalization were investigated in order to maximize the biosensor 
efficiency. Similarly, EIS signals can be affected by different factors such as the conformational 
modifications of the aptamer structure during aptamer-antigen recognition, which leads to the 
redistribution of the coverage charges and subsequent alteration of the impedance spectrum. However, 
the conformational changes are not anticipated to affect the QCM-D response as significantly, since 
the oscillating frequency change signal is more dependent on the alteration of total mass bound on the 
crystal surface and alterations in the hydration level of the bound layer, induced by the protein 
binding. 
 
2. Material and methods 
2.1.  Reagents 
Thiolated PSA aptamer (5’-HS-(CH2)6-TTT TTA ATT AAA GCT CGC CAT CAA ATA GCT TT-
3’), 6-Mercapto-1-Hexanol (MCH), Human Serum Albumin (HSA), potassium phosphate, monobasic 
solution 1 M, potassium phosphate dibasic solution 1 M, potassium sulphate, potassium 
hexacyanoferrate (III), potassium hexacyanoferrate (II) trihydrate, Tris-HCl, 
ethylenediaminetetraacetic acid (EDTA), magnesium chloride, sodium chloride and potassium 
chloride were obtained from Sigma-Aldrich (UK). Ethanol was purchased from Fisher Scientific 
(UK). PSA from human seminal fluid in PBS, pH 7.4, 0.1% NaN₃, purity ≥98% by SDS-PAGE 
(product number 539831) was purchased from Merck Chemicals Ltd (UK). Ultrapure water 
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(18.2 MΩ cm) was used for all the aqueous solutions (Millipore, USA). All other reagents were of 
analytical grade. 
 
2.2.  Immobilization procedure/ sensor fabrication 
Gold electrodes used for QCM-D and EIS measurements were incubated for 16 hours at room 
temperature, suspended in a 150 µl mixture of thiolated DNA aptamer (HS-(CH2)6-ssDNA) and 
MCH. Prior to mixing with DNA aptamer, MCH was initially diluted in ethanol to form a stock 
solution of 100 mM and then in measurement buffer and mixed with the thiolated aptamer. Various 
ratios of MCH to aptamer were combined to reach a final concentration of 100 µM of total thiol. 1:50, 
1:100, 1:200 and 1:500 ratios of aptamer:MCH were investigated in this study. In order to activate the 
DNA aptamer, the DNA sample was heated for 10 min at 95 °C and rapidly cooled down to 0 °C 
before being mixed to MCH for the sensor functionalization. Target detection was tested by adding 
11, 22, 44, 89, 200, and 400 nM of PSA. 
 
2.3. EIS system 
A µAUTOLAB III / FRA2 potentiostat (Metrohm, Netherlands) was used to perform impedance 
measurements in a three-electrode cell with a Hg/Hg2SO4 reference electrode (BASi, USA) and a 
platinum wire counter electrode (ALS, Japan). Gold electrodes of 1.0 mm radius were used as 
working electrodes (CH Instruments, USA); prior their use, the electrodes were sonicated for 10 min 
in ethanol and then mechanically polished for 5 min on polishing pads by using 50 nm alumina slurry 
(Buehler). A further 5 min sonication in ultrapure water was carried out and finally the electrodes 
were electrochemically polished by performing 50 scans of the potential between -0.05 V and +1.10 V 
versus Hg/Hg2SO4 in 0.5 M H2SO4. All the steps were followed by a thorough rinsing with ultrapure 
water. 
Impedance measurements were recorded in 0.1 M phosphate buffer, 0.1 M KCl, 10 mM 
ferri/ferrocyanide [Fe(CN)6]3-/4- (EIS measurement buffer), scanning 61 frequencies between 100 KHz 
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and 0.1 Hz applying a 10 mV a.c. voltage superimposed to the formal potential of the [Fe(CN)6]3-/4- 
redox couple (0.190 V versus Hg/Hg2SO4). All the measurements were carried out in triplicate, values 
reported in this study are the mean of replicates. Reported errors are standard deviations from the 
mean. EIS recordings were repeated every 30 min prior to the interaction with PSA until the signal 
was stable for two consecutive measurements. The impedance of the electrochemical interface was 
modelled with a Randles equivalent circuit where the double layer capacitance (Cdl) has been replaced 
by a constant phase element (CPE) in order to obtain a better estimation of the electrochemical double 
layer of the real system (Macdonald, 1984) (inset Fig. 2).  
The negative charge of the DNA aptamer produces an electrostatic barrier to the negatively charged 
redox marker [Fe(CN)6]3-/4-, which hinders the charge transfer processes between the redox marker in 
solution and the electrode. For this reason, a higher aptamer density on the electrode surface results in 
higher values of charge transfer resistance (Rct). When PSA binds to the aptamer, a conformational 
change of the DNA strand occurs with a consequent modification of the layer structure and of 
possible screening of the DNA charges. As a result, the binding of the analyte to the aptamer causes a 
change in the impedance of the system and, in particular, in Rct. 
 
2.4.  Chronocoulometry 
Chronocoulometry of aptamer-modified electrodes was performed in order to estimate the DNA 
aptamer density on the electrode surface for different ratios of MCH/aptamer. The measurements 
were performed with a µAUTOLAB III potentiostat in a three electrode system using 10 mM Tris 
buffer pH 7.4, both in the absence and presence of 100 µM of hexaammineruthenium(III) chloride, 
Ru(NH3)63+. The potential was stepped from −0.3 V, where the potential was held for 200 ms, 
to -0.8 V versus Hg/HgSO4 and held at this value for 500 ms while the resulting currents were 
recorded. The values of aptamer molecules per electrode area were calculated using a modified 
Cottrell equation (Keighley et al, 2008). 
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2.5.  QCM-D system 
Prior to modification and subsequent testing, AT-cut 5 MHz gold coated quartz crystals (QSX301) 
gold-coated quartz crystals were cleaned by exposure to a solution of 5:1:1 of ultrapure water, 
hydrogen peroxide and ammonia preheated at 75 °C for 5 minutes. Cleaned crystals were rinsed 
successively with ultrapure water, ethanol and, again, ultrapure water and dried with nitrogen gas. A 
further step of 1 min UV/ozone exposure provided the final removal of organic contaminants before 
the crystals could be used for the QCM-D measurement. 
Quartz crystals were mounted in titanium chambers and used with an E4 QCM-D sensor system (Q-
Sense, Sweden). The chamber temperature was set at 21.2 °C. DNA immobilization, PSA binding and 
measurements were performed in the same buffer in which the aptamer was raised (Savory et al., 
2010): 10 mM Tris HCl, 150 mM NaCl, 5 mM KCl, 5 mM MgCl2, pH 7.4 (TBS buffer) with an ionic 
strength of 175 mM. In order to compare the amount of PSA bound on the quartz crystal for different 
aptamer/MCH fractions, four concentrations of PSA were tested: 0, 22, 89 and 200 nM. QCM-D 
analysis made use of an Ismatec peristaltic pump, set on a flow rate of 20.0 µl/min. After finding the 
best aptamer/MCH fraction, the biosensor detection was tested with dissolved PSA concentrations 
ranging between 0 and 400 nM. Sauerbrey and Voigt masses which respectively give an approximate 
estimation of the dry and hydrated immobilised masses were calculated, using the frequency and 
dissipation values generated during protein titration. For thin, rigid films the Sauerbrey equation (1) 
states that the shift in the resonant frequency, ∆f, of a piezoelectric sensor is directly proportional to 
the amount of mass bound on the sensor surface, Δm (O’Sullivan & Guilbault, 1999):  
 ∆݉ = ஼∆௙
௡
= ஺ඥఓ೜ఘ೜
ଶ௡௙బ
మ ∆݂         (1) 
where f0 is the fundamental frequency of the quartz crystal (Hz), A the sensing area of the electrode 
(cm2), µq and ρq are the shear modulus (2.947 × 1011 g/s2 cm) and density (2.648 g/cm3) of the quartz 
crystal, respectively and n is the overtone number (n = 1, 3, 5. etc). C = 17.7 ng/ Hz cm2 is the mass 
sensitivity constant for the AT-cut 5 MHz quartz crystal used in this study.  
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For bound biomolecule layers, a percentage as high as 95% of water can be entrapped in the adsorbed 
film. When water is coupled to the biological layer, a soft and viscoelastic film can form and 
additional dampening of the quartz oscillator occurs causing an overestimation of the mass if only the 
Sauerbrey equation is used to model the system (Höök et al., 2001). By measuring both the frequency 
and dissipation factor of the quartz crystal, QCM-D can overcome this limitation providing a more 
accurate estimation of the mass of the layer (Fogel & Limson, 2011). The dissipation factor measures 
the ratio between the lost energy and the stored energy from the system during one oscillation cycle. 
The compensation of the viscous energy losses is achieved using the Voigt model (Voinova et al., 
1999; Dutta et al., 2008; Höök et al., 2001). The Voigt model was fitted using the QTools software 
(LOT-Oriel AG, Germany) by setting a film density of 1050 kg/m3 and fluid viscosity of 
0.001 kg/m s. From these bound mass responses, the dissociation constant of the PSA-immobilised 
aptamer complex was calculated 
 
3. Results and discussion 
3.1.  DNA-aptamer/MCH ratio 
In order to control the aptamer density on the gold surface, the sensor functionalization was achieved 
by means of a mixed SAM, i.e. aptamer and MCH were mixed before performing the 
functionalization step. The aptamer distribution and density play a crucial role in the biosensor 
performance (Keighley et al., 2008). For example, electrode functionalization performed with mixed 
SAMs of 1:9 and 1:200 aptamer/MCH ratio yielded signal changes of 27 and 7.5 Hz, respectively. A 
further step of MCH backfilling provided further electrode coverage due to SAM reorganization, 
coverage of pinholes in the initial SAM, and lifting of any DNA lying flat on the surface due to 
electrostatic interactions.  
Four different aptamer/MCH ratios were tested: 1:50, 1:100, 1:200 and 1:500. Preliminary results 
showed that lower aptamer/MCH ratios such as 1:9 produced a minor response (0.76%) in ΔRct upon 
addition of 300 nM PSA. The aptamer density coverage for different aptamer/MCH fraction was 
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analysed by performing chronocoulometry measurements (Fig. 3). These results were confirmed by 
EIS signals, which showed increasing values of initial Rct as the ratio is decreased: 1059 ± 43 Ω, 
1557 ± 50 Ω, 1634 ± 164 Ω and 1858 ± 161 Ω for 1:500, 1:200, 1:100 and 1:50 aptamer/MCH ratios, 
respectively, which linearly correlates with DNA aptamer density from chronocoulometry data.  
In order to evaluate the performance of the biosensor, three PSA solutions with concentrations of 22, 
89 and 200 nM were tested. By analysing the responses from the Voigt model, the four aptamer/MCH 
ratios showed different levels of hydration and of total PSA mass bound (Fig. 4). At an aptamer:MCH 
ratio of 1:200, an increase in PSA binding was recorded by the QCM-D system, relative to the other 
ratios studied. Analyzing the hydrated response, i.e. combining the dry mass response with the 
dissipation signal, the electrode functionalized with an aptamer/MCH ratio of 1:200 exhibited the 
highest response in terms of PSA binding, with an extent of pmoles/cm2 129% higher than the 
electrode functionalized with a ratio of 1:50. However, a further decrease of the aptamer fraction 
(ratio 1:500) lowered the efficiency of the biosensor as shown in Fig. 4. The trend obtained can be 
explained considering the combination of two effects: the steric hindrance effect, which prevails for 
ratios up to 1:200, and the total number of aptamer molecules available for PSA targeting, which 
becomes more consistent for a lower DNA aptamer fraction. Furthermore, QCM-D revealed the 
difference in hydration amongst the four ratios. If we divide the amount of Voigt mass, i.e. the 
hydrated mass, by the Sauerbrey mass, i.e. the dry mass, we can have an indication of the hydration 
level for each DNA aptamer/MCH fraction analysed. Respectively, 1:50, 1:100, 1:200 and 1:500 
exhibited an average hydration level across the points shown in fig. 4 of 1.01, 0.80, 1.19 and 1.37. 
The highest hydration level was, therefore, achieved for the 1:500 ratio. However, as shown in fig. 4, 
the 1:500 ratio does not guarantee enough DNA aptamer coverage in order to ensure the maximum 
PSA binding to the sensor surface.   
 
3.2.  Comparison of QCM-D and EIS data 
In order to test the performance of the system, impedance measurements were compared for PSA 
concentrations between 300 fM and 300 nM for different DNA aptamer/MCH ratios (Fig. 5). 
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Measurements showed a general trend where the biosensor impedance moved towards smaller Rct 
values upon increasing PSA concentrations as can be seen in the Nyquist plots in Fig. 2. It is 
worthwhile to highlight the negative changes in impedance signals due to PSA binding. The 
isoelectric point of the PSA is between 6.9 and 7.2 (Zhang et al., 1995), so its binding to the DNA 
aptamer is supposed to add a small increase in negative charge to the system when the biosensor is 
operated in the pH range between 7.0 and 7.4, which would increase the electrostatic barrier to the 
redox couple [Fe(CN)6]3-/4-, therefore increasing slightly Rct. The folding of the DNA aptamer into its 
secondary structure upon PSA binding increases the density of charge closer to the surface and 
expands it to a larger geometrical area – factors which should also lead to an increase in Rct. The 
presence of the bulky PSA molecules on the surface have an obstructing effect to the redox markers 
and would further hamper the electron transfer during EIS measurements. Decreases in Rct upon target 
binding to an aptamer, although not common, have been reported in a couple of systems including 
PSA (Rodriguez at al., 2005; Jolly et al., 2015b) and been attributed to a partial screening of the 
negative charge of the DNA aptamer by PSA binding, which lowers the electrostatic barrier to the 
redox markers, facilitating their approach to the sensor surface. The EIS response is in fact due to the 
combination of all the effects mentioned: a negative shift in Rct is only observed when the screening 
of the DNA aptamer charge caused by the protein binding is the dominant effect (Jolly et al., 2015b). 
Such effect was more relevant for high concentrations of PSA. The ΔRct versus [PSA] curves roughly 
follow a Hill dose response equation of the type y = y0 + (ymax - y0) cn / (kn + cn) where c is the 
concentration. However, no accurate values of the parameters can be extracted from the fits, 
presumably due to the complex dependencies of Rct on the charge and mass of the biolayer. 
It is observed that the maximum EIS signal is obtained for an aptamer/MCH ratio of 1:100. Moreover, 
the reproducibility of the EIS signals is also improved for the 1:100 aptamer/MCH ratio. The EIS 
signal depends not only on the total mass bound on the surface (for which a maximum signal is 
obtained for a 1:200 ratio as seen by the QCM-D) but also on the screening of the DNA charge, which 
is expected to be higher for more densely packed DNA layers. The LODs obtained from the EIS data 
improve as one goes from a ratio of 1:500 towards 1:200 and 1:100, where the best value was 
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obtained (<40 nM). However, for the 1:50 ratio there is a significant increase in the LOD. Correlating 
the LODs obtained from the EIS responses for different aptamer densities (inset Fig. 3), it can be seen 
that small changes of aptamer/thiols fraction can greatly affect the sensitivity towards the PSA 
detection: e.g. an increase in aptamer surface density from 1.2 to 1.5 × 1012 molecules/cm2, leads to a 
significant increase in LOD. It is this fine balance between mass loading and charge effects that leads 
to a different optimal ratio for EIS measurements. In our previous reported work (Jolly et al., 2015b), 
the stability of the aptasensor with respect to repeated EIS measurements over time was studied. It 
was also reported the effect of changing types of buffer on the impedance signal as to make a clear 
point on reliable acquisition of data reflecting only binding of PSA to the aptasensor. 
Figure 6A shows the QCM-D kinetic curves of frequency shift and dissipation changes for a 1:200 
aptamer/MCH ratio. It can be seen how increasing concentrations of PSA added to the chamber in 
flow conditions follow typical association curve responses. Moreover, PSA additions enhanced the 
viscoelastic properties of the biofilm as shown by the dissipation response. The dissipation signal 
allows estimating the mass of protein bound to the aptamer with a better accuracy. This can be 
extremely important in particular for low concentrations of PSA where a correction as large as 10 fold 
was obtained when using the Voigt model as compared to the solely dry mass response. Figure 6B 
shows the hydrated QCM-D responses for PSA and human serum albumin (HSA) obtained with the 
aptamer:MCH ratio of 1:200. QCM-D data shows a hyperbolic dose-response with an affinity 
constant Kd = 37 nM for PSA. With respect to the EIS response, a concentration as high as 100 µM of 
HSA, which is the concentration typically found in blood, produced a shift in Rct of 12 ± 6%. 
However, unlike for PSA, the shift in Rct deriving from non-specific binding of HSA is positive and, 
hence, easily distinguishable from PSA. The non-specific binding of proteins occurs primarily within 
the MCH areas, yielding an increase in Rct due to a blocking effect towards the redox couple. We 
cannot neglect that using the biosensor in presence of both proteins, this would result in a lower 
efficacy towards PSA detection. However, since the aim of this study is not to develop a PSA sensor 
but to provide a comparative study between QCM-D and EIS signals, we leave the optimization of 
such an aptasensor to further studies. 
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4. Conclusions 
In this study we investigated strategies for the optimization of an EIS aptamer-based sensor. We used 
a PSA-specific aptamer as a case study and monitored the total PSA mass bound by varying the 
binding conditions and recording QCM-D data. We found a Kd value of 37 nM for the DNA aptamer 
towards its PSA target. QCM-D results confirmed the importance of DNA surface coverage 
optimization for efficient aptamer-protein binding. In particular we found that a ratio 1:200 of 
aptamer:MCH provides the maximum PSA binding. However, EIS data demonstrated a higher DNA 
aptamer surface density (obtained for a 1:100 ratio) is required for an optimal impedimetric signal. A 
negative Rct signal change was recorded upon targeting the DNA aptamer as a result of the screening 
of the aptamer charge by bound PSA. Impedimetric measurements in aptasensors depend on the 
balance between different factors such as the antigen binding bulk effect, surface charge, and DNA 
conformational changes happening upon target binding. Therefore, the DNA aptamer surface density 
for which maximum antigen binding occurs, is not necessarily the optimal surface density for EIS 
measurements. In this study we have shown a decrease in the ΔRct signal upon targeting the DNA 
aptamer. The decrease in Rct cannot, however, be generalized for any aptamer-based sensor as the EIS 
signal is not only generated by the obstructing effect induced by the target binding but also by the 
charge and conformational redistributions that happen on the sensor surface. A direct consequence is 
that a maximum analyte binding, as here demonstrated, not always corresponds to a maximum signal 
response for an EIS sensor. Although aptamers have great potential towards the development of 
biosensors, aptasensors require a careful design in order to provide an acceptable binding efficiency. 
The results of this study can be applied to future label-free, reliable and cost effective aptamer-based 
sensors exploiting EIS.  
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Fig.1. A) Biosensor detection principle with representation of the electrode gold surface; B) EIS 
measurements showing a signal change in the Nyquist plot before (i) and after (ii) PSA binding; 
C) QCM-D measurements showing frequency and dissipation responses before (i) and after (ii) 
PSA binding. 
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Fig.2. Nyquist plot for different PSA concentrations using an aptamer/MCH ratio of 1:100. Inset: 
Randles equivalent circuit. Rs is the solution resistance, Rct is the charge transfer resistance, 
CPE is the constant phase element and W is the Warburg element. 
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Fig. 3. DNA aptamer molecule density distribution on the electrode surface vs. DNA aptamer/MCH 
molar fraction in solution. Active electrode surface: 1 mm radius. Inset: LODs obtained from 
the EIS responses for different DNA aptamer/MCH molar fraction vs. surface aptamer density 
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Fig. 4. Hydrated mass QCM-D measurements in a flow mode for PSA binding at different DNA 
aptamer/MCH ratios.  
 
 
Fig. 5. Rct change upon incubation with PSA in different SAM over range of DNA aptamer/MCH 
concentration fraction. The lines, which serve as guides to the eye, are fits of the data to a Hill 
dose response equation: y = y0 + (ymax – y0) cn / (kn + cn) where c is the concentration. 
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Fig. 6. A) Kinetic curves of frequency and dissipation response upon increasing PSA additions in 
flow-condition. Arrows indicate additions of PSA; B) Hydrated mass QCM-D response in a 
flow mode for PSA and HSA using an aptamer/MCH ratio of 1:200. Fitting is obtained by 
using a hyperbolic dose response equation y = ymax c/(Kd + c) where c is the concentration and Kd 
the affinity constant 
 
